Nordihydroguaiaretic acid
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nordihydroguaiaretic acid, covering 2012-10-11 to 2012-10-11. Get the full timeline:
Most recent: Clinical Trial Update: Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer [Phase 1]